(Q45252813)

11 December 2017

title

Effect of cyclosporin A on T cell immunity. I. Dose-dependent suppression of different murine T helper cell pathways (English)

1 reference

11 December 2017

1 reference

Fukuzawa M

1

1 reference

11 December 2017

Shearer GM

series ordinal

2

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 January 1989

1 reference

European Journal of Immunology

11 December 2017

published in

1 reference

11 December 2017

volume

19

1 reference

11 December 2017

issue

1

1 reference

11 December 2017

page(s)

49-56

1 reference

Immunosuppression for Organ Grafting Observations on Cyclosporin A

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

The Use of Cyclosporin A Immunosuppression in Organ Grafting

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

Experience with cyclosporine and steroids in clinical renal transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

Long-term use of cyclosporine in liver recipients. Reduction of dosages in the first year to avoid nephrotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

The effects of cyclosporin A on the immune system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

Frequency analysis of cyclosporine-sensitive cytotoxic T lymphocyte precursors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

Inhibition of the accessory function of murine macrophages in vitro by cyclosporine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

Sensitivity of veiled (dendritic) cells to cyclosporine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

Selective suppression of an early step in human B cell activation by cyclosporin A

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

The generation of effector T cells in influenza A-infected, cyclosporine A-treated mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

The effects of cyclosporin on lymphocyte activation in a systemic graft-vs.-host reaction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

Both L3T4+ and Lyt-2+ helper T cells initiate cytotoxic T lymphocyte responses against allogenic major histocompatibility antigens but not against trinitrophenyl-modified self

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin 2 receptor-ligand complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

Rapid data collection, analysis, and graphics for flow microfluorometry instrumentation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

Does cyclosporine act in vivo as it does in vitro?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

Gamma interferon synthesis by human thymocytes and T lymphocytes inhibited by cyclosporin A

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

Cyclosporine does not prevent cytoplasmic calcium changes associated with lymphocyte activation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

Inhibition of antigen-specific activation of an L3T4+ T cell line by cyclosporine with maintenance of macrophage-mediated antigen presentation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

Inhibition of helper function with anti-Lyt-2 or anti-L3T4 monoclonal antibodies depending on stimulating antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

Functions of purified L3T4+ and Lyt-2+ cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

Reactivity of Ly-2+ T cells against 2,4,6-trinitrophenyl (TNP)-modified syngeneic stimulator cells: specificity, frequency of interleukin 2-producing Ly-2+ helper T cells and clonal segregation from Ly-2+ cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

Functional heterogeneity of L3T4+ T cells in MRL-lpr/lpr mice. L3T4+ T cells suppress major histocompatibility complex-self-restricted L3T4+ T helper cell function in association with autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190109

7 January 2021

Identifiers

DOI

10.1002/EJI.1830190109

1 reference

release_wvwr3vrdebhqni7d4onoptfgpq

11 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wvwr3vrdebhqni7d4onoptfgpq

24 November 2022

mapped directly with Wikidata item

1 reference